MGX · Metagenomi Therapeutics, Inc.

$1.17 -0.01 (-0.85%)

Market Cap

$44.95M

37.78M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jian Irish	Ph.D., M.B.A. President and Chief Executive Officer	$570,655	—	$427,960	$402,782	$252,590	$13,933	$1,667,920
Brian C. Thomas	Former Chief Executive Officer	$563,014	—	$42,240	$191,061	—	$599,746	$1,396,061
Pamela Wapnick	M.B.A. Chief Financial Officer	$464,000	—	$210,480	$81,883	$161,101	$17,500	$934,964
Matthew L. Wein	—	$407,151	—	$163,401	$43,476	$124,856	$17,500	$756,384

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Brian C. Thomas	Chief Executive Officer	$628,333	—	$1,287,493	$3,860,492	$265,200	$19,766	$6,061,284
Jian Irish	Ph.D., M.B.A. President and Chief Operating Officer	$536,333	—	$762,496	$2,286,313	$187,000	$11,293	$3,783,435
Pamela Wapnick	M.B.A. Chief Financial Officer	$445,000	—	$749,999	$2,248,828	$122,400	$14,413	$3,580,640
General Counsel	Compliance Officer, Head of BD&L and Corporate Secretary	—	—	—	—	—	—	—

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Brian C. Thomas	Chief Executive Officer	$516,667	$20,000	$6,966,519	—	$288,600	$34,069	$7,825,855
Jian Irish	Ph.D., M.B.A. President and Chief Operating Officer	$465,000	$15,000	$1,783,211	—	$231,449	$18,368	$2,513,028
Pamela Wapnick	M.B.A. Chief Financial Officer	—	—	—	—	—	—	—

Key facts CIK 1785279 CUSIP 59102M104 13F (30d) 40 filings 40 filers Visit website Investor relations